Scientific article
English

Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?

Published in

Radiotherapy and oncology, vol. 102, no. 1, p. 62-67

Publication date

2012

Abstract

To evaluate the influence of concomitant chemotherapy on loco-regional control (LRC) and cancer-specific survival (CSS) in patients with T1-T2 N0 M0 anal cancer treated conservatively by primary radiotherapy (RT).

Keywords

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Anus Neoplasms/pathology/therapy
  • Chemoradiotherapy/methods
  • Combined Modality Therapy
  • Female
  • Fluorouracil/administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Mitomycin/administration & dosage
  • Neoplasm Staging
  • Survival Rate
  • Treatment Outcome

Citation (ISO format)

ZILLI, Thomas et al. Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy? In: Radiotherapy and oncology, 2012, vol. 102, n° 1, p. 62–67. doi: 10.1016/j.radonc.2011.09.015

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0167-8140
815views
0downloads

Technical informations

Creation

03/06/2013 13:14:00

First validation

03/06/2013 13:14:00

Update

14/03/2023 20:19:37

Status update

14/03/2023 20:19:36

Last indexation

30/10/2024 09:44:01
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated